TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$65.28
−1.89%Forward multiples
Based on analyst estimates
- P/E forward
- 33.38x
- P/E 2026E
- —
- P/E 2027E
- 20.78x
- P/E 2028E
- 14.55x
- P/S forward
- 6.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 250.93x
- Price / sales
- 10.41x
- Price / cash flow
- 66.38x
Enterprise value
- Enterprise value
- $6.3B
- EV / sales
- 10.62x
- EV / EBITDA
- 4068.06x
- EV / EBIT
- -155.25x
- Market cap
- $6.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026